Jensen Huang, FDA Commissioner Makary, & Beast Industries CEO 2/26/26

Nvidia’s recent earnings report highlights AI’s role as a new industrial revolution, with the company maintaining dominance in data center infrastructure despite emerging competition. The Pentagon is currently pressuring AI firm Anthropic for broad access to its technology, raising significant concerns regarding supply chain risks and the balance between safety and competitiveness. Meanwhile, the FDA is accelerating drug approvals for rare diseases by implementing new regulatory flexibilities, such as the plausible mechanism pathway and reduced clinical trial requirements, to address unmet patient needs. Simultaneously, Beast Industries is evolving from a single-creator brand into a diversified entertainment and fintech platform. The company is proactively establishing internal policies to prevent employees from trading on non-public information within emerging prediction markets, emphasizing the need for self-regulation in an increasingly complex digital landscape.